Notification of Major Interests in Shares

For immediate release 

11 September 2009

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Neuropharm Group plc

2. Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

3. Full name of person(s) subject to the notification obligationiii:

Barclays PLC

5. Date of the transaction and date on which the threshold is crossed or reachedv:

2 September 2009

6. Date on which issuer notified:

11 September 2009

7. Threshold(s) that is/are crossed or reached:

5% to below notifiable %

8. Notified details:

A: Voting rights attached to shares

Class/type of shares

if possible using the ISIN CODE

Situation previous to the Triggering transactionvi

Resulting situation after the triggering transactionviii

Number of Shares

Number of Voting Rightsviii

Number of shares

Number of voting rights

% of voting rights

Directx

Indirectxi

Direct

Indirect

GB00B1NPJJ01

1,626,942

1,626,942

Not Reportable

Not Reportable

Not Reportable

Not Reportable

Not Reportable

B: Financial Instruments

Resulting situation after the triggering transactionxiii

Type of financial instrument 

Expiration datexiii

Exercise/ Conversion Period/ Datexiv

Number of voting rights that may be acquired if the instrument is exercised/ converted 

% of voting rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments 

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date

Number of voting rights instrument refers to

% of voting rights 

Total (A+B+C)

Number of voting rights

% of voting rights

Not reportable

Not reportable

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will cease to hold:

N/A

12. Date on which proxy holder will cease to hold voting rights:

N/A

13. Additional information:

N/A

14. Contact name:

Geoff Smith

15. Contact telephone number:

020 7116 2913